Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability ...
Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...
An AI-powered toolkit automatically extracts and quantifies microstructural features from microscopy images, accelerating ...
12hon MSN
Multifractal patterns across deep time: What measurement density reveals about Earth's history
Much of our understanding of Earth's past is derived from stratigraphic records exposed in rock outcrops or recovered from drilled cores. These records span immense time intervals, from thousands to ...
Smithsonian researcher Sarah Johnson studies bison specimens to understand how the species’s genetic diversity changed after its decline ...
Translating regenerative medicine from lab research to large-scale clinical and commercial production requires robust, scalable, and tightly controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results